JANICE KEANE: Open Payments
NPI 1871502955 · CALUMET CITY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$604 in 24 payments from 12 companies in 2025. Trend: 2023 $1,250 · 2024 $1,287 · 2025 $604
Food & beverage: $604
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $177 |
| LEO Pharma Inc. | 3 | $68 |
| Regeneron Healthcare Solutions, Inc. | 2 | $67 |
| PFIZER INC. | 3 | $60 |
| Amgen Inc. | 2 | $50 |
| ABBVIE INC. | 2 | $37 |
| Arcutis Biotherapeutics, Inc. | 2 | $37 |
| Janssen Biotech, Inc. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Organon LLC | 2 | $25 |
Products named: DUPIXENT, ADBRY, OTEZLA, CIBINQO, Zoryve, LIBTAYO, TREMFYA, COSENTYX.
Industry payments across IL — which companies pay providers there.
